Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Annie Guérin, Eric Q. Wu, Vamsi K. Bollu, Denise Williams, Amy Guo, Diego Ponce de Leon & Alfonso Quintas-Cardama. (2013) The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Journal of Medical Economics 16:1, pages 125-133.
Read now
Read now
Articles from other publishers (15)
Fauziya, Akash Gupta, Arif Nadaf, Shadaan Ahmad, Nazeer Hasan, Mohammad Imran, Amirhossein Sahebkar, Gaurav Kumar Jain, Prashant Kesharwani & Farhan J. Ahmad. (2023) Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies. Medical Oncology 40:6.
Crossref
Crossref
Denis J. Donovan, Tamar Siskind, Maria T. Thanjan, Ralf J. Holzer, Jeffrey D. Dayton & Sheila J. Carroll. (2022) Chylous pericardial effusion with cardiac tamponade in a child treated with imatinib. Cardiology in the Young, pages 1-3.
Crossref
Crossref
Rie Aoyama, Joji Ishikawa & Kazumasa Harada. (2020) The efficacy of tolvaptan in treating dasatinib-induced pleural effusions in patients with chronic myelogenous leukemia. Journal of Cardiology 75:2, pages 203-207.
Crossref
Crossref
Chandra K. Ala, Allan L. Klein & Javid J. Moslehi. (2019) Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management. Current Cardiology Reports 21:12.
Crossref
Crossref
Marte Karen Brattås, Kyrre Lilleeng, Randi Hovland, Ingvild Jenssen Lægreid, Marta Vorland, Friedemann Leh, Øystein Bruserud, Bjørn Tore Gjertsen & Håkon Reikvam. (2018) Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis. Biomarker Research 6:1.
Crossref
Crossref
B. Cosyns. 2017. Anti-Cancer Treatments and Cardiotoxicity. Anti-Cancer Treatments and Cardiotoxicity
119
123
.
Wendy Schaffer, Dipti Gupta, Anthony Yu, Jennifer Liu, Michael Baum, Howard Weinstein, Michelle Johnson, Carol Chen, Nancy Roistacher, Shawn C. Pun, Jonathan W. Weinsaft, Eileen McAleer, John Sasso, Lee W. Jones & Richard M. Steingart. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology
379
395
.
Richard M. Steingart, Howard Weinstein, John Sasso, Lee W. Jones, Michelle Johnson, Carol Chen, Jennifer Liu, Nancy Roistacher, Shawn C. Pun, Jonathan W. Weinsaft, Eileen McAleer, Dipti Gupta, Anthony Yu, Michael Baum & Wendy Schaffer. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology
345
378
.
J. C. Plana, M. Galderisi, A. Barac, M. S. Ewer, B. Ky, M. Scherrer-Crosbie, J. Ganame, I. A. Sebag, D. A. Agler, L. P. Badano, J. Banchs, D. Cardinale, J. Carver, M. Cerqueira, J. M. DeCara, T. Edvardsen, S. D. Flamm, T. Force, B. P. Griffin, G. Jerusalem, J. E. Liu, A. Magalhaes, T. Marwick, L. Y. Sanchez, R. Sicari, H. R. Villarraga & P. Lancellotti. (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal - Cardiovascular Imaging 15:10, pages 1063-1093.
Crossref
Crossref
Juan Carlos Plana, Maurizio Galderisi, Ana Barac, Michael S. Ewer, Bonnie Ky, Marielle Scherrer-Crosbie, Javier Ganame, Igal A. Sebag, Deborah A. Agler, Luigi P. Badano, Jose Banchs, Daniela Cardinale, Joseph Carver, Manuel Cerqueira, Jeanne M. DeCara, Thor Edvardsen, Scott D. Flamm, Thomas Force, Brian P. Griffin, Guy Jerusalem, Jennifer E. Liu, Andreia Magalh?es, Thomas Marwick, Liza Y. Sanchez, Rosa Sicari, Hector R. Villarraga & Patrizio Lancellotti. (2014) Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography 27:9, pages 911-939.
Crossref
Crossref
Jessica Shank Coviello. (2014) Cardiac Side Effects of Targeted Therapies. Seminars in Oncology Nursing 30:3, pages 175-182.
Crossref
Crossref
Elisabetta Abruzzese, Massimo Breccia & Roberto Latagliata. (2013) Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML). BioDrugs 28:1, pages 17-26.
Crossref
Crossref
Victoria Campbell & Mhairi Copland. (2013) Dasatinib for the treatment of chronic phase chronic myeloid leukemia. Clinical Practice 10:4, pages 415-425.
Crossref
Crossref
Massimo Breccia & Giuliana Alimena. (2013) The role of comorbidities in chronic myeloid leukemia. Leukemia Research 37:7, pages 729-730.
Crossref
Crossref
Massimo Breccia & Giuliana Alimena. (2011) Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients. BioDrugs 25:3, pages 147-157.
Crossref
Crossref